NYSE · Medical - Care Facilities

Concord Medical Services Holdings Limited (CCM) Stock

$4.32 +7.20% NYSE: CCM Healthcare

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital.

Valuation

MetricValue
Price$4.32
Market Cap$629052
P/E Ratio-0.03
P/B Ratio0.00
P/S Ratio0.01
EPS (TTM)$-621.00
52-Week High$6.98
52-Week Low$3.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.73%
ROA-1.90%
ROCE-5.21%
Gross Margin6.88%
Operating Margin-40.87%
Net Margin-21.25%
Debt/Equity-1.73
Current Ratio0.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$486.0M$472.0M$537.0M$384.0M$461.0M
Operating Profit$-458.0M$-525.0M$-463.0M$-532.0M$-239.0M
Net Profit$-271.0M$-490.0M$-298.0M$-308.0M$-93.0M
EPS$-5635.50$-3362.70$-2044.20$-2116.80$-621.00
Op Margin-94.4%-111.2%-86.2%-138.6%-52.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.2B$6.0B$6.1B$6.7B$6.5B
Total Liabilities$3.5B$4.0B$4.3B$5.1B$4.7B
Cash$157.0M$158.0M$58.0M$216.0M$298.0M
Borrowings$2.7B$3.2B$3.3B$3.9B$3.6B

Latest News

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading MT Newswires · Jul 16, 2026 Asian Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading MT Newswires · Jul 15, 2026 Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading MT Newswires · Jun 24, 2026 Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading MT Newswires · Jun 15, 2026 Asian Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading MT Newswires · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-359.0M$-217.0M$-276.0M$-398.0M$-202.0M
Investing Cash Flow$-1.3B$-503.0M$-163.0M$-1.0B$-37.0M
Financing Cash Flow$498.0M$20.0M$195.0M$-335.0M$97.0M
Net Cash Flow$-287.0M$0$-69.0M$147.0M$62.0M
Free Cash Flow$-1.1B$-600.0M$-392.0M$-809.0M$-293.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-27.57
FCF Yield0.00%
Quick Ratio0.46
Interest Coverage-1.57
Return 1Y-23.85%
Return 3Y-69.43%
Return 5Y-84.15%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
BACKIMAC Holdings, Inc. $0.02 +0.00% -0.01 $79484 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
HEPAHepion Pharmaceuticals, Inc. $0.05 +17.78% -0.21 $617116 0.00%
IVF $0.96 -4.09% -0.01 $1.71M 0.00%

About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Concord Medical Services Holdings Limited is headquartered in CN.

Concord Medical Services Holdings Limited (CCM) stock trades at $4.32 with a market capitalization of $629052. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $3.18 and $6.98, and currently trades 38.1% below its 52-week high.

On profitability, Concord Medical Services Holdings Limited generates a return on equity (ROE) of 5.73%, return on capital employed of -5.21%, an operating margin of -40.87%, a net profit margin of -21.25%.

Official website: ir.ccm.cn

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides